Treatment with Rifamixin {51111245}
| Definition: | Treatment with Rifamixin |
|---|---|
| Queue: | [ ] |
| Initialisation date: | 2021-11-25 |
|---|---|
| Specification: | |
| [ ] | |
| Type: | Antibiotic |
|---|---|
| Host: | Human |
| Zone: | [ ] |
Notes:
[ ]
Shared Reference Notes
- [1.1] [#Alzheimer’s disease]
- Treatment with Rifamixin > significant reduction in serum neurofilament-light levels >significant increase in fecal phylum Firmicutes microbiota. Treatment with Rifamixin > reduces Serum pTau181 and GFAP levels and non-significant downward trend in serum cytokine IL-6 and IL-13 levels. Increases in stool #Erysipelatoclostridium > correlated significantly with reductions in serum pTau 181 and serum GFAP.
References Notes
[ ]